Literature DB >> 17009075

Abnormal glycosylation of serum IgG in patients with IgA nephropathy.

Hideki Homma1, Keiichi Tozawa, Takahiro Yasui, Yasunori Itoh, Yutaro Hayashi, Kenjiro Kohri.   

Abstract

BACKGROUND: We postulated that IgA nephropathy (IgAN) involved alterations of serum IgG. The present study was undertaken to elucidate changes in serum IgG oligosaccharide structure analysis and to assess the diagnostic usefulness of this analysis in IgAN.
METHODS: The subjects were 28 children who were definitively diagnosed as having IgAN on the basis of renal biopsy and who had not received treatment for this disease; 27 healthy children; 15 untreated adults definitely diagnosed as having IgAN; 5 patients with other nephropathies; and 61 healthy adults. Oligosaccharide analyses of IgG were performed by reverse-phase high-performance liquid chromatography (HPLC) developed by Takahashi and colleagues.
RESULTS: In both the children and the adults, the peak area ratio of isomers with two different galactosyl-N-acetylglucosamine (Gal-GlcNAc) binding sites was significantly lower in the presence of IgAN than in the healthy subjects (P<0.05 in children and P<0.001 in adults). The ratio of Gal-free oligosaccharides to Gal-positive oligosaccharides did not differ according to the presence or absence of IgAN in children or in adults.
CONCLUSIONS: The analysis of the oligosaccharide structure of serum IgG seems to be useful in diagnosing IgAN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009075     DOI: 10.1007/s10157-006-0422-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  21 in total

Review 1.  IgA nephropathy: recent developments.

Authors:  Jürgen Floege; John Feehally
Journal:  J Am Soc Nephrol       Date:  2000-12       Impact factor: 10.121

2.  The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients.

Authors:  O H Hashim; A S Shuib; C T Chua
Journal:  Immunol Invest       Date:  2001-02       Impact factor: 3.657

Review 3.  Application of mass spectrometry to IgA nephropathy: structural and biological analyses of underglycosylated IgA1 molecules.

Authors:  Yoshinari Yasuda; Akeyo Horie; Hiroko Odani; Hitoo Iwase; Yoshiyuki Hiki
Journal:  Contrib Nephrol       Date:  2004       Impact factor: 1.580

4.  The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjögren's syndrome (SS).

Authors:  A Bond; A Alavi; J S Axford; P Youinou; F C Hay
Journal:  Clin Exp Immunol       Date:  1996-07       Impact factor: 4.330

5.  Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.

Authors:  F P Schena; A Pastore; N Ludovico; R A Sinico; S Benuzzi; V Montinaro
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

6.  Corticosteroids in IgA nephropathy: a randomised controlled trial.

Authors:  C Pozzi; P G Bolasco; G B Fogazzi; S Andrulli; P Altieri; C Ponticelli; F Locatelli
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

Review 7.  Beta-1,4-galactosylation of N-glycans is a complex process.

Authors:  K Furukawa; T Sato
Journal:  Biochim Biophys Acta       Date:  1999-12-06

8.  Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.

Authors:  J Mestecky; M Tomana; P A Crowley-Nowick; Z Moldoveanu; B A Julian; S Jackson
Journal:  Contrib Nephrol       Date:  1993       Impact factor: 1.580

9.  Human serum immunoglobulin G3 subclass bound preferentially to asialo-, agalactoimmunoglobulin A1/Sepharose.

Authors:  H Iwase; Y Yokozeki; Y Hiki; A Tanaka; T Kokubo; T Sano; I Ishii-Karakasa; K Hisatani; Y Kobayashi; K Hotta
Journal:  Biochem Biophys Res Commun       Date:  1999-10-22       Impact factor: 3.575

10.  Charge distribution of plasma IgG and IgG immune complexes in IgA nephropathy.

Authors:  R Yasumori; P Hobby; G Williams; Y Ohzono; T Harada; K Hara
Journal:  Nihon Jinzo Gakkai Shi       Date:  1994-11
View more
  4 in total

Review 1.  Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review.

Authors:  Emanual Maverakis; Kyoungmi Kim; Michiko Shimoda; M Eric Gershwin; Forum Patel; Reason Wilken; Siba Raychaudhuri; L Renee Ruhaak; Carlito B Lebrilla
Journal:  J Autoimmun       Date:  2015-01-09       Impact factor: 7.094

2.  Alteration of N-glycosylation in the kidney in a mouse model of systemic lupus erythematosus: relative quantification of N-glycans using an isotope-tagging method.

Authors:  Noritaka Hashii; Nana Kawasaki; Satsuki Itoh; Yukari Nakajima; Toru Kawanishi; Teruhide Yamaguchi
Journal:  Immunology       Date:  2008-08-14       Impact factor: 7.397

Review 3.  Reversed-phase separation methods for glycan analysis.

Authors:  Gerda C M Vreeker; Manfred Wuhrer
Journal:  Anal Bioanal Chem       Date:  2016-11-25       Impact factor: 4.142

4.  A site-specific map of the human plasma glycome and its age and gender-associated alterations.

Authors:  Alexander A Merleev; Dayoung Park; Yixuan Xie; Muchena J Kailemia; Gege Xu; L Renee Ruhaak; Kyoungmi Kim; Qiuting Hong; Qiongyu Li; Forum Patel; Yu-Jui Yvonne Wan; Alina I Marusina; Iannis E Adamopoulos; Nelvish N Lal; Anupum Mitra; Stephanie T Le; Michiko Shimoda; Guillaume Luxardi; Carlito B Lebrilla; Emanual Maverakis
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.